Archived Webinar

Practical Considerations on the FDA CFL Guidance

Abraham Gitterman, Senior Associate
Arnold & Porter

Recorded on June 25, 2020

Topics Include:

  • Internal Collaborations and Concept Review
  • Practical considerations for implementing the CFL Guidance
  • Best practices in applying the three CFL factors

This webinar is available for download for $249.

Regulatory Affairs, Advertising & Promotion
Promotional Regulatory Affairs
Advertising & Promotional Review
Regulatory Affairs Advertising, Promotion & Labeling
Regulatory Affairs – Commercialization

Life Sciences


Abraham Gitterman
Senior Associate
Arnold & Porter

Abraham Gitterman is a Life Sciences/Healthcare Associate at Arnold & Porter Kaye Scholer LLP in Washington, DC, where he focuses on FDA and healthcare regulatory, compliance, and fraud and abuse matters involving pharmaceutical and medical device manufacturers. He regularly counsels clients on FDA-regulated advertising and promotion, including use of digital and social media; compliant medical affairs activities, including continuing medical education (CME); appropriate interactions with healthcare professionals; and mobile health applications. Mr. Gitterman currently and regularly serves on Promotional Review Committees (PRCs) across various therapeutic areas and throughout product life cycles.

For More Information, Contact:

Brooke AkinsBrooke Akins
Division Director, Life Science Programs
+1 (312) 224-1693​